HOME >> BIOLOGY >> NEWS
Sperm Protein May Hold Clues For Fertility And Contraceptives

A protein found on the surface of the sperm of all mammals appears crucial for the union of the sperm and egg, as well as for movement of the sperm into the animal's oviduct, announce researchers at the University of California, Davis.

The discovery, which has direct implications for human fertility research as well as development of male contraceptives, is reported in the Sept. 18 issue of the journal Science.

"We suspected that sperm lacking the protein known as fertilin-beta would not be able to penetrate the egg, but we were quite surprised that these sperm even failed to bind with the egg's outer coating and rarely were able to travel from the uterus to the oviduct," said researcher Chunghee Cho. He is a molecular biologist and postdoctoral fellow from Korea working in the laboratory of UC Davis fertility researchers Diana Myles and Paul Primakoff.

The researchers studied the activity of sperm in mice lacking the gene for fertilin-beta, which belongs to a family of proteins found on the surface of cells and is believed to be important in cell binding.

Sperm from the mutant mice looked and moved normally, but most of them failed to attach to the egg. These sperm fused with the plasma membrane, which encases the egg, at just half the rate of sperm from normal mice.

Cho and colleagues anticipated this binding failure at the plasma membrane, but were surprised that the defective sperm were not even binding with the zona pellucida, the thick transparent wall that forms the outermost covering of the egg.

Furthermore, the sperm lacking fertilin-beta seemed unable to migrate from the uterus into the oviduct where the eggs are housed. The researchers speculate that this may be because the mutant sperm were unable to temporarily cling to the lining of the juncture of the uterus and oviduct as they normally would before proceeding into the oviduct.

The fertility rate of the male mice lacking fertilin-beta was 98 percent less than that of the no
'"/>

Contact: Patricia Bailey
pjbailey@ucdavis.edu
(530) 752-9843
University of California - Davis
17-Sep-1998


Page: 1 2

Related biology news :

1. Sperm use heat sensors to find the egg
2. Sperm and germ-fighting contraceptive enters trials
3. Sperm counts unchanged over 50 years
4. Male Moths Sperm Protects Females
5. Eggs Fertilised By More Than One Sperm Can Survive
6. Gene Once Thought To Program Ovarian Development Instead Found To Be Critical For Production Of Sperm
7. Bacteria That Disable Sperm
8. UB Fertility Researchers Find They Can Predict Pregnancy By Assessing Two Sperm Abnormalities
9. The First Rejection: Eggs Sequester Bits Of Sperm For Later Elimination
10. Reanalysis Of International Data Finds Sharp Decline In Sperm Density
11. Stress Lowers Sperm Count By Overwhelming Cells That Make Testosterone

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Sperm Protein May Hold Clues For Fertility And Contraceptives

(Date:12/3/2014)... Calif. , Dec. 2, 2014   ... globally deployed, innovative test solutions for military, aerospace, ... newest version of its successful TS-900 PXI ... performance and features of high-end systems to customers ... outstanding value compared to traditional ATE. ...
(Date:11/21/2014)... , Nov. 19, 2014  Earlier this year ... York College, and one of the most prolific inventors ... that are transmitted from Smartphones to third party agencies. ... and has one of the earliest known patents in ... usage in the military, child care, elder care and ...
(Date:11/21/2014)... 20, 2014   Atmel® Corporation (NASDAQ: ... and touch technology solutions, today launched the industry,s first ... the widest V cc range from 1.7V to ... faster I 2 C bus communication speeds, and are ... making them ideal for consumer, industrial, computer, and medical ...
Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
(Date:12/17/2014)... (PRWEB) December 17, 2014 Xeno ... Excellence following its most recent COLA inspection. Xeno ... COLA, a national healthcare accreditation organization. Accreditation is ... of quality in day-to-day operations, demonstrate continued accuracy ... a rigorous on-site laboratory survey. , ...
(Date:12/17/2014)...  Vermillion, Inc. (NASDAQ: VRML ), a ... the next step in its expanded strategy to rebuild ... the naming of current Chief Operating Officer, Valerie ... current Chairman of the Board and CEO James ... changes are effective January 1, 2015. "Jim ...
(Date:12/17/2014)... SAN FRANCISCO, Calif. , Dec. 17, 2014 ... results of a Phase 2 study evaluating the ... the treatment of patients with severe, chronic itch ... current standard of care, including topical steroids and ... was percent change in Visual Analog Scale (VAS) ...
(Date:12/15/2014)... TIKVAH, Israel , Dec. 15, 2014 ... ), a leading developer of adult stem cell technologies ... Cell Therapeutics Ltd. was awarded a grant of approximately ... of the Chief Scientist (OCS).  This is the eighth ... support from the Office of the Chief Scientist, which ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 2BrainStorm Receives $1,100,000 for its 8th Annual Non-Dilutive Grant from Israel's Chief Scientist Office 3
Cached News: